Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
SZLS | Toronto | CAD | Real-time | |
SZLS | CBOE Canada | CAD | Real-time |
For the three months ended 31 March 2022, StageZero Life Sciences Ltd revenues decreased 47% to $1.3M. Net loss decreased 92% to $590K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Loss (gain) from fair valuation of warra decrease from $5.5M (expense) to $1.3M (income), FV Adjustments of Financial Investments decrease from $1.5M (expense) to $0K.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 1.32 | 1.5 | 0.68 | 0.4 |
Gross Profit | -0.04 | -0.04 | -0.12 | -0.21 |
Operating Income | -0.59 | -2.3 | -2.22 | 4.33 |
Net Income | -0.59 | -2.3 | -2.22 | 4.33 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 9.33 | 10.65 | 10.39 | 6.41 |
Total Liabilities | 6.44 | 7.88 | 6.82 | 5.9 |
Total Equity | 2.89 | 2.76 | 3.57 | 0.51 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -2.24 | -8.95 | -6.1 | -3.55 |
Cash From Investing Activities | 0 | -0.02 | -0.1 | -0.1 |
Cash From Financing Activities | 1.13 | 4.1 | 1.19 | 1.29 |
Net Change in Cash | -1.12 | -4.87 | -5.01 | -2.35 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review